Navega Therapeutics
0 followers
Navega Therapeutics has developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific, and long-lasting. Navega Therapeutics has imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way.
Org chart
Ana Moreno
Founder & CEO
Ana Moreno
Collapse
Fernando Aleman
Co-founder & CSO
Carol Greve-Philips
Chief Business Officer
Kris Elverum
Member Of The Board Of Advisors
